Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1971 Oct 30;4(5782):275–276. doi: 10.1136/bmj.4.5782.275

Thyrotoxicosis developing during cyclophosphamide therapy.

I R McDougall, W R Greig, H W Gray, J F Smith
PMCID: PMC1799552  PMID: 5171386

Full text

PDF
275

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burrow G. N., Mitchell M. S., Howard R. O., Morrow L. B. Immunosuppressive therapy for the eye changes of Graves' disease. J Clin Endocrinol Metab. 1970 Sep;31(3):307–311. doi: 10.1210/jcem-31-3-307. [DOI] [PubMed] [Google Scholar]
  2. Chopra I. J., Solomon D. H. Graves' disease with delayed hyperthyroidism. Onset after several years of euthyroid ophthalmopathy, dermopathy, and high serum LATS. Ann Intern Med. 1970 Dec;73(6):985–990. doi: 10.7326/0003-4819-73-6-985. [DOI] [PubMed] [Google Scholar]
  3. GOLDBERG R. C., GREEP R. O., NAY L. B., Jr Modification of thyroid activity in absence of the anterior pituitary gland. Proc Soc Exp Biol Med. 1953 Dec;84(3):621–624. doi: 10.3181/00379727-84-20732. [DOI] [PubMed] [Google Scholar]
  4. KRISS J. P., PLESHAKOV V., CHIEN J. R. ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA. J Clin Endocrinol Metab. 1964 Oct;24:1005–1028. doi: 10.1210/jcem-24-10-1005. [DOI] [PubMed] [Google Scholar]
  5. Lipman L. M., Green D. E., Snyder N. J., Nelson J. C., Solomon D. H. Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease. Am J Med. 1967 Oct;43(4):486–498. doi: 10.1016/0002-9343(67)90175-1. [DOI] [PubMed] [Google Scholar]
  6. McKENZIE J. M. The bioassay of thyrotropin in serum. Endocrinology. 1958 Sep;63(3):372–382. doi: 10.1210/endo-63-3-372. [DOI] [PubMed] [Google Scholar]
  7. ODELL W. D., BATES R. W., RIVLIN R. S., LIPSETT M. B., HERTZ R. Increased thyroid function without clinical hyperthyroidism in patients with choriocarcinoma. J Clin Endocrinol Metab. 1963 Jul;23:658–664. doi: 10.1210/jcem-23-7-658. [DOI] [PubMed] [Google Scholar]
  8. SNYDER N. J., GREEN D. E., SOLOMON D. H. GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE. J Clin Endocrinol Metab. 1964 Nov;24:1129–1135. doi: 10.1210/jcem-24-11-1129. [DOI] [PubMed] [Google Scholar]
  9. Werner S. C., Platman S. R. Remission of hyperthyroidism (Graves' disease) and altered pattern of serum-thyroxine binding induced by prednisone. Lancet. 1965 Oct 16;2(7416):751–755. doi: 10.1016/s0140-6736(65)90810-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES